NIDCR combats oral complications of cancer treatment.
D000970:Antineoplastic Agents / Q000009:adverse effects; D006801:Humans; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000628:therapy*; D009909:Oral Health; D011832:Radiation Injuries; D014481:United States
D000970:Antineoplastic Agents